DBL Institute for Health Research and Development

DBL Institute for Health Research and Development is the dedicated research and development arm of the DBL Group, a major conglomerate based in Bangladesh. The institute primarily supports the operations of DBL Pharmaceuticals by conducting formulation development, bioequivalence studies, and clinical research to ensure the quality and efficacy of generic medicines. It gained significant prominence for its involvement in large-scale clinical trials, including Phase 3 trials for COVID-19 vaccines in collaboration with international partners. The organization focuses on bridging the gap between academic research and industrial application to improve healthcare standards and accessibility in the South Asian region.